What’s Hot Today: Bristol-Myers Squibb Company (NYSE:BMY), Minerva Neurosciences (NASDAQ:NERV), Intel Corporation (NASDAQ:INTC), Zions Bancorporation (NASDAQ:ZION), ICU Medical (NASDAQ:ICUI)

On Thursday shares of Bristol-Myers Squibb Company (NYSE:BMY) closed at $67.45. Company’s sales growth for last 5 years was -3.30% and EPS growth for next 5 years is recorded as 16.39%. Bristol-Myers Squibb Company (NYSE:BMY) announced that pursuant to its previously announced cash tender offer for up to $400 million aggregate principal amount (the “tender cap”) of certain of its outstanding debt securities approximately $534.4 million in aggregate principal amount of the notes.

Minerva Neurosciences, Inc. (NASDAQ:NERV) in last trading activity fell -1.55% to close at $5.07. Company weekly performance is -1.55% while its quarterly performance stands at 10.58%. Minerva Neurosciences, Inc. (NASDAQ:NERV) is -49.30% away from its 52 week high. Minerva Neurosciences Inc. (NASDAQ:NERV) on 7 May, reported a loss of $6.1 million in its first quarter. The Waltham, Massachusetts-based company said it had a loss of 31 cents per share. Minerva Neurosciences shares have fallen 15 percent since the beginning of the year.

Intel Corporation (NASDAQ:INTC) in last trading activity advanced 1.01% to close at $32.97. Company weekly performance is 2.26% while its quarterly performance stands at -2.70%. Intel Corporation (NASDAQ:INTC) is -11.75% away from its 52 week high. Intel Corporation (NASDAQ:INTC) announced plans to develop integrated products with eASIC Corporation that combine processing performance and customizable hardware to meet the increasing demand for custom compute solutions for data centers and the “cloud.”

Zions Bancorporation (NASDAQ:ZION) has 1.20% insider ownership while its institutional ownership stands at 87.10%. In last trading activity company’s stock closed at $29.16. Scott J. McLean, President of Zions Bancorporation (NASDAQ: ZION), will make a presentation at the Barclays Americas Select Franchise Conference 2015 on Tuesday, May 19, 2015 at 1:00 p.m. BST.

On last trading day ICU Medical, Inc. (NASDAQ:ICUI) increased 1.73% to close at $96.56. Its volatility for the week is 2.38% while volatility for the month is 2.43%. ICUI’s sales growth for past 5 years was 6.20% and its EPS growth for past 5 years was 0.10%. ICU Medical, Inc. (NASDAQ:ICUI) monthly performance is 6.14%. ICU Medical Inc. (NASDAQ:ICUI) on 5 May, reported first-quarter net income of $9.7 million. The San Clemente, California-based company said it had net income of 60 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.02 per share.

Top Wall Street Stories: Ericsson (NASDAQ:ERIC), Bristol-Myers Squibb Company (NYSE:BMY), IntelliPharmaCeutics International Inc. (NASDAQ:IPCI), Meta Financial Group (NASDAQ:CASH)

On Monday shares of Ericsson (NASDAQ:ERIC) closed at $10.97. Company’s sales growth for last 5 years was 2.00% and EPS growth for next 5 years is recorded as 9.40%. On 30 April, Ericsson (NASDAQ:ERIC) announced that Gartner, Inc., the world’s leading information technology research and advisory company, continues to position Ericsson as an LTE industry leader within the “Leaders” quadrant of its 2015 Magic Quadrant for LTE Infrastructure report, now for the sixth year running

On last trading day Bristol-Myers Squibb Company (NYSE:BMY) moved up 1.02% to close at $65.32. Its volatility for the week is 1.73% while volatility for the month is 1.74%. BMY’s sales growth for past 5 years was -3.30% and its EPS growth for past 5 years was -5.90%. Bristol-Myers Squibb Company (NYSE:BMY) monthly performance is 3.31%. On 28 April, Bristol-Myers Squibb Company (NYSE:BMY) reported a profit of $1.19 billion, or 71 cents a share, up from $937 million, or 56 cents a share, a year earlier. Excluding pension-related charges, asset-sale gains and other items, per-share earnings in the year earlier quarter were 46 cents. Sales rose 6% to $4.04 billion. Analysts polled by Thomson Reuters had expected per-share profit of 50 cents on revenue of $3.8 billion.

IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) has 0.93% insider ownership while its institutional ownership stands at 0.50%. In last trading activity company’s stock closed at $2.98. TheStreet upgraded shares of IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) from a sell rating to a hold rating in a research report released on Wednesday morning.

On last trading day Meta Financial Group, Inc. (NASDAQ:CASH) advanced 2.60% to close at $40.72. Its volatility for the week is 3.15% while volatility for the month is 2.42%. CASH’s sales growth for past 5 years was 5.80% and its EPS growth for past 5 years was 45.60%. Meta Financial Group, Inc. (NASDAQ:CASH) monthly performance is 2.00%.On 30 April, Meta Financial Group, Inc. (NASDAQ:CASH) reported results for Fiscal 2015 Second Quarter. MFG’s fiscal 2015 second quarter net income totaled $5.2 million versus $4.1 million in the second quarter of 2014. Fiscal year-to-date net income for the six months ended March 31, 2015, was $8.8 million, compared to $8.1 million for the comparable prior year period. Excluding $1.2 million related to losses on securities, $0.5 million of acquisition-related expenses and $0.5 million for historic insurance claim reimbursements, fiscal year-to-date earnings after tax would have been $9.6 million.

Hot News: United States Steel Corp. (NYSE:X), General Motors Company (NYSE:GM), Bristol-Myers Squibb Company (NYSE:BMY), Rayonier Inc. (NYSE:RYN), ANN INC. (NYSE:ANN)

On Wednesday shares of United States Steel Corp. (NYSE:X) closed at $23.67. Company’s sales growth for last 5 years was 9.60% and EPS growth for next 5 years is recorded as -3.93%. Barclays set a $24.00 price target on shares of United States Steel (NYSE:X) stock in a research note issued on Tuesday. The firm currently has a “hold” rating on the stock.

On Wednesday shares of General Motors Company (NYSE:GM) closed at $35.51. Company’s sales growth for last 5 years was 8.30% and EPS growth for next 5 years is recorded as 18.16%. General Motors Co. (NYSE:GM) plans to announce on Thursday that it will invest several billion dollars on its North American manufacturing plants over multiple years, according to report citing people familiar with the matter.

Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity decreased -0.39% to close at $64.29. Company weekly performance is -3.47% while its quarterly performance stands at 5.43%. Bristol-Myers Squibb Company (NYSE:BMY) is -6.56% away from its 52 week high. Bristol-Myers Squibb Company (NYSE:BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) for the treatment of previously untreated patients with unresectable or metastatic melanoma. The FDA also granted Priority Review for this application. The projected FDA action date is August 27, 2015.

On last trading day Rayonier Inc. (NYSE:RYN) fell -0.46% to close at $25.85. Its volatility for the week is 1.04% while volatility for the month is 1.25%. RYN’s sales growth for past 5 years was -12.40% and its EPS growth for past 5 years was -30.20%. Rayonier Inc. (NYSE:RYN) monthly performance is -4.01%. Rayonier Inc. (NYSE:RYN) plans to release its first quarter 2015 earnings on Wednesday, May 6, 2015, after the market closes.

ANN INC. (NYSE:ANN) has 2.10% insider ownership while its institutional ownership stands at 92.40%. In last trading activity company’s stock closed at $37.61. On April 27, ANN INC. (NYSE:ANN), donated more than $4.3 million to the Breast Cancer Research Foundation® (BCRF) to fund groundbreaking cancer research from the success of the brand’s 2014 spring and fall campaigns, bringing the Company’s total corporate donation to $22.3 million in the past 10 years.

Hot Stocks: Energy Transfer Partners, L.P. (NYSE:ETP), Statoil ASA (NYSE:STO), WESCO International Inc. (NYSE:WCC), Bristol-Myers Squibb Company (NYSE:BMY), Murphy Oil Corporation (NYSE:MUR)

On Wednesday shares of Energy Transfer Partners, L.P. (NYSE:ETP) closed at $55.30. Company’s sales growth for last 5 years was 56.70% and EPS growth for next 5 years is recorded as 6.00%. Energy Transfer Partners, L.P. (NYSE:ETP) announced that its Board of Directors has approved a $0.02 increase in its quarterly distribution to $1.015 per ETP common unit ($4.06 annualized) for the quarter ended March 31, 2015.

Statoil ASA (NYSE:STO) in last trading activity increased 0.44% to close at $20.47. Company weekly performance is 5.84% while its quarterly performance stands at 22.80%. Statoil ASA (NYSE:STO) is -34.44% away from its 52 week high. Despite challenging oil and gas prices in the quarter, Statoil (NYSE:STO) delivered Adjusted earnings of NOK 22.9 billion and NOK 7.0 billion after tax. Statoil reports a negative IFRS Net income of NOK 35.4 billion due to impairments.

On last trading day WESCO International Inc. (NYSE:WCC) increased 1.17% to close at $71.63. Its volatility for the week is 3.29% while volatility for the month is 2.24%. WCC’s sales growth for past 5 years was 11.30% and its EPS growth for past 5 years was 16.10%. WESCO International Inc. (NYSE:WCC) monthly performance is 1.96%. On April 27, WESCO International, Inc. (NYSE:WCC), announced that WESCO Distribution, Inc. has entered into a definitive agreement to acquire Hill Country Electric Supply. Closing is expected to occur in May 2015.

Bristol-Myers Squibb Company (NYSE:BMY) has 0.10% insider ownership while its institutional ownership stands at 72.60%. In last trading activity company’s stock closed at $64.29. Bristol-Myers Squibb Co. (NYSE:BMY) announced that the U.S. Food and Drug Administration or FDA has accepted for filing and review the supplemental Biologics License Application or sBLA for Opdivo(nivolumab)for the treatment of previously untreated patients with unresectable or metastatic melanoma. The FDA also granted Priority Review for this application. The projected FDA action date is August 27, 2015.

On last trading day Murphy Oil Corporation (NYSE:MUR) increased 1.63% to close at $49.19. Its volatility for the week is 2.13% while volatility for the month is 2.14%. MUR’s sales growth for past 5 years was -20.60% and its EPS growth for past 5 years was 8.90%. Murphy Oil Corporation (NYSE:MUR) monthly performance is 3.19%. Murphy Oil Corp. (NYSE:MUR) on Wednesday reported a first-quarter loss of $14.4 million, after reporting a profit in the same period a year earlier.

Best Stocks: MIND C.T.I., (NASDAQ:MNDO), Seacoast Banking Corp. of Florida (NASDAQ:SBCF), Vical Incorporated (NASDAQ:VICL), Mitsubishi UFJ Financial (NYSE:MTU), Bristol-Myers Squibb (NYSE:BMY)

On Monday shares of MIND C.T.I., Ltd. (NASDAQ:MNDO) closed at $2.70. Company’s sales growth for last 5 years was -1.00%. MIND C.T.I., Ltd. (NASDAQ:MNDO) announced results for its first quarter ended March 31, 2015. Revenues were $5.7 million, same as in the first quarter of 2014 and compared with $6.5 million in Q4 2014.Operating income was $1.6 million, or 27% of total revenues, up from $1.1 million in the first quarter of 2014 or 20% of total revenues.

On last trading day Seacoast Banking Corp. of Florida (NASDAQ:SBCF) moved down -0.07% to close at $14.19. Its volatility for the week is 2.11% while volatility for the month is 1.87%. SBCF’s sales growth for past 5 years was -4.70% and its EPS growth for past 5 years was 15.00%. Seacoast Banking Corp. of Florida (NASDAQ:SBCF) monthly performance is -0.21%. Seacoast Banking Corporation of Florida (NASDAQ:SBCF), announced that it will release first quarter results on Tuesday, April 28, 2015, after the market closes.

Vical Incorporated (NASDAQ:VICL) has 1.90% insider ownership while its institutional ownership stands at 40.90%. In last trading activity company’s stock closed at $0.96. On Aprl 22, Vical Incorporated (NASDAQ:VICL) announced that it has entered into a $4 million contract with the IPPOX Foundation to manufacture HIV-antigen plasmid DNA as a component of vaccine regimens to be evaluated in clinical trials for the prevention of HIV infection. IPPOX is a Swiss non-profit foundation that participates in the conduct of HIV vaccine clinical trials under the auspices of the Pox-Protein Public-Private Partnership (P5), funded by the Bill & Melinda Gates Foundation and the U.S. National Institute of Allergy and Infectious Diseases (NIAID).

On Monday shares of Mitsubishi UFJ Financial Group, Inc. (NYSE:MTU) closed at $7.25. Company’s EPS growth for next 5 years is recorded as -6.50%. MUFG Americas Holdings Corporation (NYSE:MTU), parent company of San Francisco-based MUFG Union Bank, N.A., reported first-quarter net income to company of $137 million, compared to $172 million for the year-ago quarter.

Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity fell -0.97% to close at $65.16. Company weekly performance is -1.06% while its quarterly performance stands at 4.92%. Bristol-Myers Squibb Company (NYSE:BMY) is -5.29% away from its 52 week high. Bristol-Myers Squibb Company (NYSE:BMY) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Opdivo (nivolumab), a PD-1 immune checkpoint inhibitor, be granted approval for use in both first-line and previously treated patients with advanced (unresectable or metastatic) melanoma. This is the first positive opinion given by the CHMP for a PD-1 immune checkpoint inhibitor, and it will now be reviewed by the European Commission, which has the authority to approve medicines for the European Union (EU).

Why Making Dramatic Moves: Inovio Pharmaceuticals (NASDAQ:INO), Huttig Building Products Inc. (NASDAQ:HBP), Eleven Biotherapeutics (NASDAQ:EBIO), Bristol-Myers Squibb (NYSE:BMY), Adamis Pharmaceuticals (NASDAQ:ADMP)

On Thursday shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) closed at $10.60. Company’s sales growth for last 5 years was 2.90%. On 22 April, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) declared that it has initiated a phase I trial to evaluate Inovio’s DNA immunotherapy in patients who are chronically infected with hepatitis B.

Huttig Building Products Inc. (NASDAQ:HBP) in last trading activity advanced 12.25% to close at $3.94. Company weekly performance is 20.12% while its quarterly performance stands at 17.26%. Huttig Building Products Inc. (NASDAQ:HBP) is -27.71% away from its 52 week high. Huttig Building Products, Inc. (NASDAQ: HBP) reported financial results for the first quarter ended March 31, 2015. Net income in the first quarter of 2015 was breakeven compared to a net loss of $4.0 million in the first quarter of 2014. First quarter of 2015 results reflected a $0.1 million charge from discontinued operations compared to a $3.2 million charge for the first quarter of 2014.

On last trading day Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) advanced 1.74% to close at $10.50. Its volatility for the week is 5.29% while volatility for the month is 7.55%. Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) monthly performance is 9.49%. Eleven Biotherapeutics (NASDAQ:EBIO) announced that one oral presentation and two posters have been selected for presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2015 Annual Meeting taking place May 3-7, 2015, in Denver, CO.

Bristol-Myers Squibb Company (NYSE:BMY) has 0.10% insider ownership while its institutional ownership stands at 72.60%. In last trading activity company’s stock closed at $66.00. Vetr upgraded shares of Bristol-Myers Squibb (NYSE:BMY) from a strong sell rating to a sell rating in a report issued on Tuesday. They currently have $62.33 target price on the stock.

On last trading day Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) advanced 2.15% to close at $4.76. Its volatility for the week is 5.70% while volatility for the month is 8.19%. ADMP’s EPS growth for past 5 years was 22.10%. Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) monthly performance is -21.58%.Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) on 16 April, announced the results of a clinical efficacy trial that was conducted outside of the United States for its albuterol HFA product, APC-2000.

Investors Are Watching: CTI BioPharma Corp. (NASDAQ:CTIC), Navidea Biopharmaceuticals, Inc (NYSEMKT: NAVB), Potash Corp. (NYSE:POT), Bristol-Myers Squibb (NYSE:BMY), Provident Financial Services (NYSE:PFS)

On Thursday shares of CTI BioPharma Corp. (NASDAQ:CTIC) closed at $1.91. Company’s sales growth for last 5 years was 259.60%. Stock analysts at Roth Capital set a $4.50 target price on shares of CTI BioPharma Corp. (NASDAQ:CTIC) stock in a report issued on Monday. The firm currently has a “buy” rating on the stock. Roth Capital’s target price would indicate a potential upside of 131.36% from the stock’s previous close.

Navidea Biopharmaceuticals, Inc (NYSEMKT: NAVB) in last trading activity moved up 1.97% to close at $1.55. Company weekly performance is -2.52% while its quarterly performance stands at -13.89%. Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) is -23.27% away from its 52 week high. Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) said that, it will present 2015 American Head & Neck Society Annual Meeting & Translational Research Meeting on April 21 – 23, 2015 Boston, MA

Potash Corp. of Saskatchewan, Inc. (NYSE:POT) in last trading activity moved up 0.67% to close at $33.11. Company weekly performance is 1.78% while its quarterly performance stands at -3.72%. Potash Corp. of Saskatchewan, Inc. (NYSE:POT) is -10.91% away from its 52 week high. Potash Corp. of Saskatchewan, Inc. (NYSE:POT) announced that its Board of Directors has approved an increase of the company’s quarterly cash dividend (from $0.35 per share to$0.38 per share), and declared a quarterly cash dividend of US $0.38 per common share payable May 4, 2015 to shareholders of record on April 13, 2015.

On last trading day Bristol-Myers Squibb Company (NYSE:BMY) moved up 0.39% to close at $63.68. Its volatility for the week is 2.02% while volatility for the month is 1.87%. BMY’s sales growth for past 5 years was -3.30% and its EPS growth for past 5 years was -5.90%. Bristol-Myers Squibb Company (NYSE:BMY) monthly performance is -5.28%. Bristol-Myers Squibb Company (NYSE:BMY) said that, it will announce results for the first quarter of 2015 on Tuesday, April 28, 2015. During a conference call at 11 a.m. EDT on April 28, company executives will review financial information and will address inquiries from investors and analysts.

On last trading day Provident Financial Services, Inc. (NYSE:PFS) moved down -0.05% to close at $18.67. Its volatility for the week is 1.59% while volatility for the month is 1.46%. PFS’s sales growth for past 5 years was -0.90% and its EPS growth for past 5 years was 20.70%. Provident Financial Services, Inc. (NYSE:PFS) monthly performance is 0.21%. Provident Financial Services, Inc. (NYSE:PFS) announced that it expects to release financial results for the quarter ended March 31, 2015 on Friday, April 24, 2015 at approximately 8:00 a.m. Eastern Time.

Fast Moving Stocks: ChannelAdvisor Corporation (NYSE:ECOM), Bristol-Myers Squibb Company (NYSE:BMY), Hancock Holding Company (NASDAQ:HBHC), Merck & Co. Inc. (NYSE:MRK), Simpson Manufacturing (NYSE:SSD)

On Wednesday shares of ChannelAdvisor Corporation (NYSE:ECOM) closed at $11.15. Company’s sales growth for last 5 years was 18.90% and EPS growth for next 5 years is recorded as 20.00%. ChannelAdvisor Corporation (NYSE:ECOM) participated in Demandware’s 2015 XChange Conference, took place April 13-15 at the Aria Resort & Casino in Las Vegas. ChannelAdvisor was a Silver sponsor of this event and had experts available throughout the three-day conference to discuss ongoing trends in e-commerce, as well as the ChannelAdvisor platform.

Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity decreased -0.94% to close at $63.43. Company weekly performance is -0.14% while its quarterly performance stands at 1.07%. Bristol-Myers Squibb Company (NYSE:BMY) is -7.81% away from its 52 week high. On April 8, Bristol-Myers Squibb Company (NYSE:BMY) announced that it has completed the previously announced planned acquisition of Flexus Biosciences Inc. The transaction includes full rights to F001287 Flexus’ lead preclinical small-molecule IDO1-inhibitor targeted for IND filing in the second half of 2015 and an IDO/TDO discovery program that includes its IDO-selective IDO/TDO dual and TDO-selective compound libraries.

On last trading day Hancock Holding Company (NASDAQ:HBHC) increased 3.19% to close at $31.07. Its volatility for the week is 2.87% while volatility for the month is 2.51%. HBHC’s sales growth for past 5 years was 16.40% and its EPS growth for past 5 years was -1.50%. Hancock Holding Company (NASDAQ:HBHC) monthly performance is 3.98%. On Tuesday Nasdaq and EverFi honored Hancock Holding Company (NASDAQ:HBHC) with the Innovation in Financial Education Award at a ceremony hosted at Nasdaq’s Marketsite headquarters in New York City. The award recognizes the company’s significant efforts to improve the financial knowledge and capabilities of young Americans. Only 25 financial institutions received this distinction.

On Wednesday shares of Merck & Co. Inc. (NYSE:MRK) closed at $58.45. Company’s sales growth for last 5 years was 9.00% and EPS growth for next 5 years is recorded as 4.55%. Merck & Co Inc. (NYSE:MRK) and NewLink Genetics have confirmed that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has begun in Sierra Leone. The Phase II/III safety and effectiveness STRIVE trial will involve 6,000 health and other frontline workers, and is being led by the Sierra Leone College of Medicine and Allied Health Sciences, Sierra Leone Ministry of Health and Sanitation, and the US Centres for Disease Control and Prevention.

On last trading day Simpson Manufacturing Co., Inc. (NYSE:SSD) increased 0.58% to close at $36.67. Its volatility for the week is 1.85% while volatility for the month is 1.84%. SSD’s sales growth for past 5 years was 7.40% and its EPS growth for past 5 years was 34.80%. Simpson Manufacturing Co., Inc. (NYSE:SSD) monthly performance is -0.65%. DA Davidson cut shares of Simpson Manufacturing Co (NYSE:SSD) from a buy rating to a neutral rating in a research report sent to investors on Monday morning,TheFlyOnTheWall.com reports. The firm currently has $40.00 price target on the stock. The analysts noted that the move was a valuation call.

Stocks in News: Bristol-Myers Squibb Company (NYSE:BMY), Host Hotels & Resorts (NYSE:HST), Galena Biopharma Inc (NASDAQ:GALE), CSX Corp. (NYSE:CSX)

On 15 April, Bristol-Myers Squibb Company (NYSE:BMY) shares moved down -0.94% and was closed at $63.43. BMY EPS growth in last 5 year was -5.90%. Bristol-Myers Squibb Company (NYSE:BMY) year to date (YTD) performance is 8.08%. Bristol-Myers Squibb Company (NYSE:BMY) said that, it will announce results for the first quarter of 2015 on Tuesday, April 28, 2015.

Host Hotels & Resorts, Inc. (NYSE:HST) in last trading activity decreased -0.15% to close at $19.93. Company weekly performance is -1.29% while its quarterly performance stands at -15.26%. Host Hotels & Resorts, Inc. (NYSE:HST) is -17.16% away from its 52 week high. On 14 April, Host Hotels & Resorts, Inc. (NYSE:HST) announced that as part of a leadership reorganization of its investment team, James F. Risoleo, currently executive vice president and managing director –Europe, has also assumed managing director responsibilities for all the company’s West Coast investment activities. Nathan S. Tyrrell, currently senior vice president and treasurer, has become managing director of investment activities in the East.

On last trading day Galena Biopharma Inc (NASDAQ:GALE) remains unchanged to close at $1.45. Its volatility for the week is 4.25% while volatility for the month is 4.16%. GALE’s EPS growth for past 5 years was 24.20%. Galena Biopharma Inc (NASDAQ:GALE) monthly performance is 3.57%. On 14 April, Galena Biopharma Inc (NASDAQ:GALE) announced the completion of enrollment in the NeuVax™ (nelipepimut-S) Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment) clinical trial. NeuVax™ is a first-in-class, HER2-directed cancer immunotherapy under evaluation to prevent breast cancer recurrence after standard of care treatment in the adjuvant setting.

CSX Corp. (NYSE:CSX) belongs to Services sector. Its net profit margin is 18.30% and weekly performance is -1.17%. On last trading day company shares ended up $32.86. CSX Corp. (NYSE:CSX) distance from 50-day simple moving average (SMA50) is -4.28%. On 14 April, CSX Corp. (NYSE:CSX) reported a higher quarterly net profit on increased freight volumes and higher rates charged to customers, and announced a $2 billion share repurchase program. The Jacksonville, Florida-based company reported first-quarter net income of $442 million or 45 cents per share, an 11 percent increase over the $398 million, or 40 cents a share, it reported a year earlier.

Hot Alert: Google Inc (NASDAQ:GOOG), Bristol-Myers Squibb Company (NYSE:BMY), STMicroelectronics NV (NYSE:STM), Express Scripts Holding Company (NASDAQ:ESRX), VimpelCom (NASDAQ:VIP)

On Wednesday shares of Google Inc (NASDAQ:GOOG) closed at $532.53. Company’s EPS growth for next 5 years is recorded as 11.90%. Google Inc (NASDAQ:GOOG) and Yelp engaged in an unusual online debate over the extent of Yelp’s reliance on Google, as European officials charged Google with violating antitrust law.

Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity fell -0.94% to close at $63.43. Company weekly performance is -0.14% while its quarterly performance stands at 1.07%. Bristol-Myers Squibb Company (NYSE:BMY) is -7.81% away from its 52 week high.Bristol-Myers Squibb Company (NYSE:BMY) said that, it will announce results for the first quarter of 2015 on Tuesday, April 28, 2015.

On last trading day STMicroelectronics NV (NYSE:STM) moved up 0.21% to close at $9.43. Its volatility for the week is 1.18% while volatility for the month is 1.50%. STM’s sales growth for past 5 years was -2.70% and its EPS growth for past 5 years was 16.10%. STMicroelectronics NV (NYSE:STM) monthly performance is -1.67%. STMicroelectronics NV (NYSE:STM) has been given a “BBB-” credit rating by analysts at Morningstar. The research firm’s “BBB-” rating indicates that the company is a moderate default risk. They also gave their stock a two star rating.

Express Scripts Holding Company (NASDAQ:ESRX) shares fell -1.14% in last trading session and ended the day at $87.06. ESRX Gross Margin is 8.30% and its return on assets is 3.70%. Express Scripts Holding Company (NASDAQ:ESRX) quarterly performance is 4.16%. Express Scripts Holding Company (NASDAQ:ESRX) said that, it will screen all ingredients in compound drug claims to ensure they are safe and effective, and covered by TRICARE, Starting May 1, 2015,
Top of Form

On last trading day VimpelCom Ltd. (NASDAQ:VIP) moved up 0.68% to close at $5.88. Its volatility for the week is 4.45% while volatility for the month is 4.54%. VIP’s sales growth for past 5 years was 17.40% and its EPS growth for past 5 years was -18.40%. VimpelCom Ltd. (NASDAQ:VIP) monthly performance is 11.79%. VimpelCom Ltd. (NASDAQ:VIP) said that, it will leverage Openmind’s Traffic Control Platform to support SMS traffic in Moscow and Central Russia during normal and peak periods.